@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns1:approve . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:10.246647"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "for the treatment of Cytokine release syndrome ( CRS ) or cytokine storm in India" . rdf:OBJECT-POSITION rdfs:label "(73, 106)" . rdf:PREDICATE rdfs:label "approved" . rdf:PREDICATE-POSITION rdfs:label "112" . rdf:SUBJECT rdfs:label "Steroids ( Methylprednisolone or Dexamethasone ) and Tocilizumab ( TCZ ) , an interleukin-6 receptor antagonist" . rdf:SUBJECT-POSITION rdfs:label "(73, 106)" . rdf:Statement rdfs:label "Steroids (Methylprednisolone or Dexamethasone) and Tocilizumab (TCZ), an interleukin-6 receptor antagonist, are approved for the treatment of Cytokine release syndrome (CRS) or cytokine storm in India." . rdfs:ABSTRACT-UID ns3:50 "9wycjlj5" . rdfs:TRIPLE-UID ns2:9wycjlj5-TRIPLE-ABSTRACT-1 "9wycjlj5-TRIPLE-ABSTRACT-1" . rdfs:label "cytokine storm" . rdfs:label "interleukin-6 receptor antagonist" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }